Links
[1] http://www.eahp.eu/content/seminar-2-2018-academy-seminars-individual-learning-assessment-questionnaire
[2] https://www.eahp.eu/sites/default/files/1._concept_of_therapeutic_drug_monitoring_tdm.pdf
[3] http://www.eahp.eu/content/prof-branislava-miljkovi%C4%87
[4] https://www.eahp.eu/sites/default/files/2._practical_consideration_to_tdm.pdf
[5] http://www.eahp.eu/content/prof-dr-azucena-aldaz-pastor
[6] https://www.eahp.eu/sites/default/files/3._population_pharmacokinetic_analysis_of_tdm_in_optimising_therapy.pdf
[7] http://www.eahp.eu/content/kees-neef
[8] https://www.eahp.eu/sites/default/files/4._tdm_and_dose_optimisation_of_antibiotics_and_antifungals.pdf
[9] http://www.eahp.eu/content/prof-dr-daniel-j-touw
[10] https://www.eahp.eu/sites/default/files/5._tdm_and_dose_optimisation_of_antiepileptic_and_antipsychotic_drugs.pdf
[11] http://www.eahp.eu/content/prof-dr-christoph-hiemke
[12] https://www.eahp.eu/sites/default/files/6._an_overview_of_therapeutic_drug_monitoring_software_0.pdf
[13] http://www.eahp.eu/content/nieko-punt
[14] https://www.eahp.eu/sites/default/files/7._tdm_and_dose_optimisation_of_immunosuppressive_and_oncolytic_agents.pdf
[15] http://www.eahp.eu/content/dr-erik-van-maarseveen
[16] https://www.eahp.eu/sites/default/files/8._workshop._clinical_cases_on_dose_adjustments_based_on_tdm_of_immunosuppressives_and_oncolytic_agents.pdf
[17] https://www.eahp.eu/sites/default/files/9._workshop_business_case_on_implementation_of_tdm_in_hospital.pdf
[18] http://www.eahp.eu/content/antonio-gouveia
[19] https://www.eahp.eu/sites/default/files/10._clinical_cases_on_dose_adjustments_based_on_tdm_of_antibiotics_and_antifungals.pdf
[20] https://www.eahp.eu/sites/default/files/11._clinical_cases_on_dose_adjustments_based_on_tdm_of_antiepileptic_and_antipsychotic_drugs.pdf